Connect with NIDA:

Treatment Research News Releases

Email FacebookTwitter

FDA approves first medication to reduce opioid withdrawal symptoms (May 16, 2018)
Announcement.
Study upends conventional view of opioid mechanism of action (May 10, 2018)
NIH-funded scientists find new molecular target for developing safer pain medications.
Nearly half of opioid-related overdose deaths involve fentanyl (May 01, 2018)
Announcement.
Dr. Kurt Rasmussen to lead NIDA’s therapeutics and medical consequences division (April 30, 2018)
Brings expertise in neuroscience therapeutics.
Study changes long-held concepts of cell decoding (March 28, 2018)
NIH scientists discover macromolecular complexes that could enable medication development.
Non-psychoactive cannabinoid may enable drug addiction recovery (March 26, 2018)
Science Spotlight.
Medication in Prison Associated with Reductions in Fatal Opioid Overdoses After Release (February 14, 2018)
Science Spotlight.
Kappa Opioid Receptor Structure Revealed, A Potential Milestone in Medication Development (January 04, 2018)
Science Spotlight.
Opioid treatment drugs have similar outcomes once patients initiate treatment (November 14, 2017)
NIDA study compares buprenorphine/naloxone combination to extended release naltrexone.
NIDA hosts sessions on pain at APA annual meeting (May 11, 2017)
Media Availability.
Medication plus ongoing care provided in emergency departments is promising approach for opioid dependence (February 23, 2017)
Science Spotlight.
Multi agency funding announcement to assist with opioid crisis in rural U.S. regions (October 07, 2016)
Announcement.
Buprenorphine Prescribers Treat Below Current Patient Limits (September 20, 2016)
Science Spotlight.
Recruitment begins for landmark study of adolescent brain development (September 13, 2016)
More than 10,000 children will participate in study of brain, social, emotional, and cognitive development.
Brain region may manage reward expectations and responding (August 17, 2016)
Science Spotlight.
Smoking cessation success linked to sex difference (July 11, 2016)
Science Spotlight.
Co-prescribing naloxone in primary care settings may reduce ER visits (June 28, 2016)
Science Spotlight.
Addiction treatment patients trained to manage their healthcare may have better outcomes (June 22, 2016)
Science Spotlight.
Pioneering early stage researchers selected for NIDA’s 2016 Avenir awards (June 09, 2016)
Awards recognize cutting edge HIV/AIDS and epigenetics research.
NIDA creates online resource to raise awareness about naloxone (June 02, 2016)
Announcement.
FDA approves six month implant for treatment of opioid dependence (May 26, 2016)
Announcement.
Advancing psychiatric practice through the science of addiction (May 05, 2016)
Media Availability.
Extended-release naltrexone lowers relapse rates in ex-offenders (March 31, 2016)
Science Spotlight.
Naloxone prescriptions from pharmacies increased ten-fold (February 18, 2016)
Science Spotlight.
Review article reinforces support for brain disease model of addiction (January 28, 2016)
Announcement.
New policies to reduce opioid prescribing not likely to have caused increase in heroin use (January 13, 2016)
Science Spotlight.
FDA approves naloxone nasal spray to reverse opioid overdose (November 18, 2015)
Announcement.
NIDA redesigns Easy to Read and Learn the Link websites for mobile devices (October 13, 2015)
Announcement.
NIH launches landmark study on substance use and adolescent brain development (September 25, 2015)
Thirteen grants awarded to look at cognitive and social development in ~10,000 children.
NIDA and NIAAA commentary strongly supports brain disease model of addiction (July 29, 2015)
Announcement.

Pages

Resources for the Media

Featured Publication

NIDA Media Guide

Connecting the scientific community and the media